Allergy Therapeutics plc (AGYTF)

Allergy Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	21.68	12.92	14.85	20.52	40.27	36.96
Cash & Short-Term Investments	21.68	12.92	14.85	20.52	40.27	36.96
Cash Growth	60.30%	-13.00%	-27.64%	-49.06%	8.96%	34.70%
Accounts Receivable	8.62	2.86	2.37	2.69	2.96	3.49
Other Receivables	-	3.35	2.69	3.21	1.66	2.16
Receivables	8.62	6.21	5.06	5.91	4.62	5.65
Inventory	11.87	12.74	11.59	11.41	10.84	10.13
Prepaid Expenses	-	1.62	2.03	4.56	1.6	2.42
Other Current Assets	-	-	-	-	0.53	-
Total Current Assets	42.17	33.48	33.53	42.39	57.86	55.17
Property, Plant & Equipment	23.32	23.75	23.24	20.19	19.72	20.42
Goodwill	3.3	3.32	3.35	3.35	3.34	3.47
Other Intangible Assets	1.21	1.37	1.79	1.69	1.41	1.27
Other Long-Term Assets	2.98	2.91	4.87	5.33	5.76	5.9
Total Assets	72.97	64.83	66.77	72.95	88.09	86.23
Accounts Payable	14.23	4.01	4.09	4.28	2.9	2.22
Accrued Expenses	-	11.82	12.49	11.34	13.55	12.86
Current Portion of Long-Term Debt	0.5	0.6	0.65	0.95	0.96	0.83
Current Portion of Leases	1.45	1.52	1.16	1.32	0.79	1.44
Other Current Liabilities	10.24	2.59	0.18	0.16	0.03	0.89
Total Current Liabilities	26.43	20.55	18.57	18.05	18.23	18.23
Long-Term Debt	36.96	22.5	26.44	1.5	2.45	2.93
Long-Term Leases	5.61	6.37	7.75	6.76	6.97	6.99
Long-Term Deferred Tax Liabilities	0.37	0.38	0.45	0.41	0.41	0.47
Other Long-Term Liabilities	1.96	2.71	3.58	0.14	0.21	0.3
Total Liabilities	80.12	61.12	64.7	35.18	39.55	42.44
Common Stock	4.78	4.77	0.68	0.64	0.64	0.64
Additional Paid-In Capital	154.64	154.64	119.03	112.58	112.58	112.58
Retained Earnings	-210.22	-198.93	-161.87	-118.54	-107.4	-112.96
Comprehensive Income & Other	43.65	43.23	44.23	43.09	42.72	43.53
Shareholders' Equity	-7.15	3.71	2.07	37.77	48.54	43.78
Total Liabilities & Equity	72.97	64.83	66.77	72.95	88.09	86.23
Total Debt	44.52	30.99	35.99	10.53	11.17	12.18
Net Cash (Debt)	-22.84	-18.07	-21.14	9.99	29.1	24.78
Net Cash Growth	-	-	-	-65.69%	17.42%	-0.88%
Net Cash Per Share	-0.00	-0.00	-0.03	0.02	0.04	0.04
Filing Date Shares Outstanding	4,766	4,766	679.1	644.1	641.77	637.29
Total Common Shares Outstanding	4,766	4,766	679.1	644.1	641.77	637.29
Working Capital	15.74	12.94	14.96	24.34	39.63	36.94
Book Value Per Share	-0.00	0.00	0.00	0.06	0.08	0.07
Tangible Book Value	-11.66	-0.98	-3.07	32.73	43.78	39.05
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.05	0.07	0.06
Land	-	3.01	3.05	3.08	3.09	11.87
Machinery	-	36.96	33.68	29.66	27.35	26.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.